Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Sleep Apnea is a common disorder which results in disturbed or poor quality of sleep. It is mainly caused by breathing pauses or shallow breathing during sleep. To treat sleep apnea, a wide range of diagnostic and therapeutic medical devices are being used. North American sleep apnea devices market is expected to rise, as the device manufacturers are continuously developing and improving their devices to increase efficiency, patient compliance and cost-effectiveness. Technological advances in mask designs, improved designs of CPAP, Bi-level, APAP devices and increased service support for PAP device users are expected to stimulate the growth of this market. North American sleep apnea market can be segmented by type of devices used such as diagnostic devices and therapeutic devices. Sleep diagnostics devices are further segmented as portable monitoring, traditional PSG/ in-lab PSG, two channel screening devices, single channel screening devices, actigraphy, respiratory polygraphs and masks. Further sleep therapeutics devices are segmented as PAP devices, adaptive servoventilation (ASV), airway clearance systems, oxygen devices and oral Appliance.
The sleep apnea market is estimated and forecasted in terms of revenue (in USD million) generated by the sleep apnea devices from 2019 to 2024. It is expected that the North American sleep apnea market is estimated to grow at CAGR 8.39% during the period of 2018 to 2023. However sleep therapeutics devices recorded more than 50% of market share in 2016 and it is expected to expand at a highest CAGR during the forecast period 2019 to 2024. By 2024 Canadian sleep apnea market revenue is expected to across USD 1.0 billion with the CAGR of ~ 10%. Some other factors driving the sleep apnea devices market are rise in awareness of sleep related disorders and growing prevalence of sleep apnea disorders.
Factors which are affecting the sleep apnea devices market are comfort to use devices, cost of treatment and difficulty in the diagnostics. The report includes in-depth analysis of market drivers, restraints, market trends and competitive landscape across various geographies. The competitive landscape section includes all market deals of last 3 years of sleep apnea devices market. It includes new product launches, mergers and acquisitions, joint ventures, agreements etc. The market size is estimated and forecasted by utilizing fundamental inputs gathered from comprehensive data extraction of both free and paid sources which are further validated by primary interviews and various macro-economic factors which affects the market. Market data extraction was not limited to sleep apnea devices market but also extracted for all related markets which affects or influences the sleep apnea devices market to see relative growth. Free sources were used for data extraction like association, standardization institutions and key company websites, annual reports, journals etc. Paid sources such as Factiva, Bloomberg, One Source etc. were also used.
Key companies which lead the market are BMC Medical Co. Ltd, Carefusion, Corp, Compumedics, Ltd, DeVilbiss Healthcare, Fisher & Paykel Healthcare, Natus Medical, Inc., Philips Respironics, ResMed, Inc. and Weimann Medical Devices. which are also profiled in the report. Each company profile includes company financials, detailed product portfolio and recent developments.
Why to buy this report:
